Every trade that managers of Critical Outcome Technologies Inc. disclose to SEDI is tracked on this page. Critical Outcome Technologies Inc. has had no insider filing for more than a year; the last one goes back to 23 September 2017.
Our records for Critical Outcome Technologies Inc. go back to 2016, with 4 purchases and 10 sales on the open market in total.
These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
· cache
25 of 70 declarations
Critical Outcome Technologies Inc. is a biotechnology company focused on developing treatments for serious diseases. It employs an innovative approach to identify and develop drug candidates.